an enzyme-linked immunosorbent assay ( elisa ) has been developed with an antiserum elicited against cisplatin-modified dna and used to quantify the intrastrand bidentate d ( gpg ) - and d ( apg ) -diammineplatinum adducts in dna samples prepared from nucleated blood cells and tissues of cancer patients receiving cisplatin or carboplatin chemotherapy .
C0012854
dna
C0242958
adducts